重症尿路感染症におけるDIC に対する遺伝子組み換えトロンボモジュリンの使用経験

HANDLE Web Site 被引用文献1件 オープンアクセス

書誌事項

タイトル別名
  • Experience in the Treatment with Recombinant Thrombomodulin on Disseminated Intravascular Coagulation with Severe Urinary Tract Infection
  • ジュウショウ ニョウロ カンセンショウ ニ オケル DIC ニ タイスル イデンシ クミ カエ トロンボモジュリン ノ シヨウ ケイケン

この論文をさがす

抄録

Severe urinary tract infection occasionally causes urosepsis and disseminated intravascular coagulation (DIC). We experienced six cases of DIC with severe urinary tract infection from July 2009 to January 2011. Patientscompris ed two men and four women, ranging in age from 67-84 years old. In all cases, urinary tract infection was caused by pyelonephritis. The results of analysis of bacterial culture from blood and urine revealed E. faecalis in 2 cases, E. coli in 1 case, P. mirabilis in 1 case and Candida tripicalis in 1 case. Percutaneous nephrostomy in 1 case and ureteral stent indwelling in 3 cases and ureteral stent exchange in 2 cases were used for the drainage of the origin of infection. Under the diagnosis of DIC, the administration of antibioticsand anti-DIC treatment with recombinant thrombomodulin (rTM) were performed. rTM isa new drug for the treatment of DIC. rTM bindsto thrombin to inactivate coagulation, and the thrombinrTM complex activatesprotein C to form activated protein C. Therefore, rTM actsasa negative feedback regulator of blood coagulation. Treatment with rTM improved in 5 of the 6 patients.

収録刊行物

  • 泌尿器科紀要

    泌尿器科紀要 58 (2), 71-74, 2012-02

    泌尿器科紀要刊行会

被引用文献 (1)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ